SAGE Therapeutics

SAGE Therapeutics

SAGE Therapeutics

SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.
Founded
2011
Raised
$93M
Follow us
Alexa global traffic share
Latest funding Show all
$38,000,000
Venture capital (Series C) - 2014
Foresite Capital ARCH Venture Partners OrbiMed Advisors +2
$20,000,000
Venture capital (Series B) - 2013
ARCH Venture Partners Third Rock Ventures
Team Size
10+
Employees
Xconomy

Caveats But No "Quicksand" In Sage's Positive Postpartum Trial Data

Health
The Motley Fool

Here's Why Sage Therapeutics' Stock Is Falling Today

Health Stock markets